Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Humblet

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|March 29, 2011
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancerK Zaman, X Durando, J-F Baurain, et al.
Bone Marrow Transplantation|September 1, 1996
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT studyL Perey, G Rosti, A Lange, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
Bulletin Du Cancer|July 1, 1997
[Efficiency of high-dose FEC chemotherapy for the mobilization of hematopoietic stem cells into peripheral blood]L D'Hondt, M André, J L Canon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancerX Pivot, S Wadler, C Kelly, et al.
Bone Marrow Transplantation|September 14, 1999
Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantationL D'Hondt, J Wuu, M André, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanomaT Kivelä, S Suciu, J Hansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximabW De Roock, H Piessevaux, J De Schutter, et al.
British Journal of Cancer|November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumabS Siena, M Peeters, E Van Cutsem, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|March 29, 2011
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancerK Zaman, X Durando, J-F Baurain, et al.
Bone Marrow Transplantation|September 1, 1996
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT studyL Perey, G Rosti, A Lange, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
Bulletin Du Cancer|July 1, 1997
[Efficiency of high-dose FEC chemotherapy for the mobilization of hematopoietic stem cells into peripheral blood]L D'Hondt, M André, J L Canon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancerX Pivot, S Wadler, C Kelly, et al.
Bone Marrow Transplantation|September 14, 1999
Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantationL D'Hondt, J Wuu, M André, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanomaT Kivelä, S Suciu, J Hansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximabW De Roock, H Piessevaux, J De Schutter, et al.
British Journal of Cancer|November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumabS Siena, M Peeters, E Van Cutsem, et al.
Pageof 8